You just read:

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

News provided by

Eli Lilly and Company

Dec 08, 2019, 16:30 ET